Global Regenerative Academy (GRA) has appointed Prof. Dr. Nesrin Erçelen, a faculty member at Üsküdar University Faculty of Medicine, as its Director of Regulatory Affairs. Prof. Dr. Erçelen brings significant contributions to the GRA team with her years of experience in clinical research. In this new role, Erçelen will oversee the creation and implementation of guidelines ensuring the safety and efficacy of regenerative therapies.
Content
GRA Appoints Prof. Dr. Nesrin Erçelen as Director of Regulatory Affairs

Prof. Dr. Nesrin Erçelen, a faculty member at Üsküdar University Faculty of Medicine, has been appointed as the Director of Regulatory Affairs for the Global Regenerative Academy (GRA).
In her new role, Dr. Erçelen will help ensure that treatments comply with international standards and are safely implemented worldwide.
Prof. Dr. Nesrin Erçelen: "My aim is to ensure treatments are accessible..."
Prof. Dr. Nesrin Erçelen, a faculty member at Üsküdar University Faculty of Medicine, stated regarding her new position: "I am honored to join GRA and be part of such an important endeavor. As we advance into areas such as cell therapies, strong regulatory frameworks are crucial for the safe use of regenerative medicine. My aim is to help GRA continue to set the highest standards in this rapidly evolving field and ensure these therapies are safe, effective, and widely accessible."
GRA President Dr. Dzihan Abazovic: "We are delighted to have Prof. Dr. Nesrin Erçelen with us"
GRA President Dr. Dzihan Abazovic commented on Prof. Dr. Nesrin Erçelen's new role. Abazovic said: "We are delighted to have Prof. Dr. Nesrin Erçelen with us. With her expertise, she will ensure that all our treatments are developed with the highest safety and compliance standards. Regulatory oversight is crucial for advancing regenerative medicine and ensuring patients benefit from the latest innovations in a controlled manner."



